Bacillus Calmette-Guérin vaccine induces a selective serotonin reuptake inhibitor (SSRI)-resistant depression like phenotype in mice

Brain, Behavior, and Immunity

Volumn 42, Issue , 2014, Pages 204-211

  Vijaya Kumar, K ^a   Rudra, Anjuman ^a   Sreedhara, M V ^a   Siva Subramani, T ^a   Prasad, Durga Shiva ^a   Das, Manish Lal ^a   Murugesan, Senthil ^a   Yadav, Rajbharan ^a   Trivedi, Ravi Kumar ^a   Louis, Justin V ^a   Li, Yu Wen ^b   Bristow, Linda J ^b   Naidu, Pattipati S ^a   Vikramadithyan, Reeba Kannimel ^b  

^a SYNGENE INTERNATIONAL LTD   (India)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

BCG vaccine; Forced swim test; Indoleamine 2,3 dioxygenase; Major depressive disorder; Neuroinflammation; Serum sickness; SSRI resistance; Tail suspension test

Indexed keywords

BCG VACCINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; GAMMA INTERFERON; IMIPRAMINE; INDOLEAMINE 2,3 DIOXYGENASE; NOMIFENSINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; CITALOPRAM; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVITY; FORCED SWIM TEST; HIPPOCAMPUS; IMMOBILITY; IN VITRO STUDY; LOCOMOTION; MAJOR DEPRESSION; MALE; MOUSE; NONHUMAN; PHENOTYPE; SERUM SICKNESS; TAIL SUSPENSION TEST; TREATMENT RESISTANT DEPRESSION; ANIMAL; ANIMAL BEHAVIOR; BAGG ALBINO MOUSE; BLOOD; BRAIN; CHEMICALLY INDUCED; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY;

ANIMALS; BCG VACCINE; BEHAVIOR, ANIMAL; BRAIN; CITALOPRAM; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FLUOXETINE; INTERFERON-GAMMA; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; PHENOTYPE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 84908614308     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.06.205     Document Type: Article

References (28)

1. Banati R.B. Visualising microglial activation in vivo. Glia 2002, 40:206-217.
2. Converse P.J., Almeida D.V., Nuermberger E.L., Grosset J.H. BCG-mediated protection against Mycobacterium ulcerans infection in the mouse. PLoS Negl. Trop. Dis. 2011, 5:e985. 10.1371/journal.pntd.0000985.
3. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56. 10.1038/nrn2297.
4. DellaGioia N., Hannestad J. A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci. Biobehav. Rev. 2010, 34:130-143. 10.1016/j.neubiorev.2009.07.014.
5. Dobos N., de Vries E.F.J., Kema I.P., Patas K., Prins M., Nijholt I.M., Dierckx R.A., Korf J., den Boer J.A., Luiten P.G.M., Eisel U.L.M. The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J. Alzheimers Dis. 2012, 28:905-915. 10.3233/JAD-2011-111097.
6. Eller T., Vasar V., Shlik J., Maron E. Proinflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:445-450.
7. Janelidze S., Mattei D., Westrin A., Traskman-Bendz L., Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav. Immun. 2011, 25:335-339. 10.1016/j.bbi.2010.10.010.
8. Kelly K.W., Bluthe R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., Broussard S.R. Cytokine-induced sickness behavior. Brain Behav. Immun. 2003, 17:S112-S118. 10.1016/S0889-1591(02)00077-6.
9. Lapidus K.A.B., Soleimani L., Murrough J.W. Novel glutamatergic drugs for the treatment of mood disorders. Neuropsychiatr. Dis. Treat. 2013, 9:1101-1112. 10.2147/NDT.S36689.
10. Lengyel K., Peischl P., Strong T., Molski T., Mattson G., Lodge N.J., Li Yu-Wen Ex-vivo assessment of binding site occupancy of monoamine reuptake inhibitors: methodology and biological significance. Neuropharmacology 2008, 55:63-70. 10.1016/j.neuropharm.2008.04.014.
11. Maes M. Major depression and activation of the inflammatory response system. Adv. Exp. Med. Biol. 1999, 461:25-46.
12. Maes M., Leonard B.E., Myint A.M., Kubera M., Verkerk R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:702-721. 10.1016/j.pnpbp.2010.12.017.
13. Meyer J.H. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J. Psychiatry Neurosci. 2007, 32:86-102.
14. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741. 10.1016/j.biopsych.2008.11.029.
15. Moreau M., Lestage J., Verrier D., Mormede C., Kelley K.W., Dantzer R., Castanon N. Bacillus Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2, 3-dioxygenase in mice. J. Infect. Dis. 2005, 192:537-544.
16. Moreau M., Andre C., O'Connor J.C., Dumich S.A., Woods J.A., Kelley K.W., Dantzer R., Lestage J., Castanon N. Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. Brain Behav. Immun. 2008, 22:1087-1095. 10.1016/j.bbi.2008.04.001.
17. O'Brien S.M., Scully P., Fitzgerald P., Scott L.V., Dinan T.G. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J. Psychiatr. Res. 2007, 41:326-331. 10.1016/j.jpsychires.2006.05.013.
18. O'Connor J.C., Andre C., Wang Y., Lawson M.A., Szegedi S.S., Lestage J., Castanon N., Kelley K.W., Dantzer R. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to Bacillus Calmette-Guerin. J. Neurosci. 2009, 29:4200-4209. 10.1523/JNEUROSCI.5032-08.2009.
19. O'Connor J.C., Lawson M.A., Andre C., Briley E.M., Szegedi S.S., Lestage J., Castanon N., Herkenham M., Dantzer R., Kelley K.W. Induction of IDO by Bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J. Immunol. 2009, 182:3202-3212. 10.4049/jimmunol.0802722.
20. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R., et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14:511-522. 10.1038/sj.mp.4002148.
21. Orsal A.S., Blois S.M., Bermpohl D., Schaefer M., Coquery N. Administration of interferon-alpha in mice provokes peripheral and central modulation of immune cells, accompanied by behavioral effects. Neuropsychobiology 2008, 58:211-222. 10.1159/000201718.
22. Piser T.M. Linking the cytokine and neurocircuitry hypotheses of depression: a translational framework for discovery and development of novel anti-depressants. Brain Behav. Immun. 2010, 24:515-524. 10.1016/j.bbi.2010.02.006.
23. Platt B., Schulenberg J., Klee N., Nizami M., Clark J.A. A depressive phenotype induced by Bacille Calmette Guerin in 'susceptible' animals: sensitivity to antidepressants. Psychopharmacology 2013, 226:501-513. 10.1007/s00213-012-2923-6.
24. Samuels B.A., Leonardo E.D., Gadient R., Williams A., Zhou J., David D.J., Gardier A.M., Wong E.H., Hen R. Modeling treatment-resistant depression. Neuropharmacology 2011, 61:408-413. 10.1016/j.neuropharm.2011.02.017.
25. Schmidt H.D., Shelton R.C., Duman R.S. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 2011, 36:2375-2394. 10.1038/npp.2011.151.
26. Wichers M.C., Koek G.H., Robaeys G., Verkerk R., Scharpe S., Maes M. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol. Psychiatry 2005, 10:538-544. 10.1038/sj.mp.4001600.
27. Yirmiya R. Depression in medical illness: the role of the immune system. West. J. Med. 2000, 173:333-336.
28. Yirmiya R., Pollak Y., Barak O., Avitsur R., Ovadia H., Bette M., Weihe E., Weidenfeld J. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 2001, 24:531-544. 10.1016/S0893-133X(00)00226-8.